SCHEMBL4092498

SCHEMBL4092498

O=C(COCc1ccccc1)Nc1cccc(C(=O)Nc2ccccc2C(=O)O)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.60
MEN1 O00255 3/20 0.60
PKM P14618 1/20 0.60
NR1H4 Q96RI1 4/20 0.54
POLB P06746 2/20 0.52
KDM4E B2RXH2 2/20 0.52
ALDH1A1 P00352 2/20 0.52
PTPRC P08575 1/20 0.51
PTPN1 P18031 1/20 0.51
GAA P10253 1/20 0.51
CTSV O60911 1/20 0.49
CTSL P07711 1/20 0.49
SUCNR1 Q9BXA5 1/20 0.49
KCNK3 O14649 1/20 0.49
KCNK9 Q9NPC2 1/20 0.49
PPARG P37231 1/20 0.48
PPARD Q03181 1/20 0.48
PPARA Q07869 1/20 0.48
NPC1 O15118 1/20 0.48
MAPT P10636 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13870767 0.89 KMT2A (0.57) KMT2AMEN1PKMNR1H4ALDH1A1
SCHEMBL13870842 0.86 KMT2A (0.67) KMT2AMEN1PKMNR1H4POLB
SCHEMBL4093077 0.84 MAPT (0.63) KMT2AMEN1PKMALDH1A1GAA
SCHEMBL8482565 0.83 KDM4E (0.73) KMT2AMEN1POLBKDM4EALDH1A1
SCHEMBL14855642 0.81 KMT2A (0.79) KMT2AMEN1PKMNR1H4POLB
SCHEMBL13870851 0.81 RAB9A (0.67) KMT2AMEN1PKMPOLBKDM4E
SCHEMBL13870846 0.81 HCAR2 (0.71) KMT2AMEN1PKMPOLBALDH1A1
SCHEMBL4097178 0.81 KMT2A (0.60) KMT2AMEN1PKMPOLBALDH1A1
SCHEMBL3503890 0.79 MEN1 (0.63) KMT2AMEN1PKMNR1H4KDM4E
SCHEMBL13870829 0.79 KMT2A (0.67) KMT2AMEN1POLBKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090105218-A1 CRTH2 Receptor Ligands For Therapeutic Use 7TM PHARMA A/S (DK) 2009-04-23 US disclosed
EP-1758571-A1 CRTH2 RECEPTOR LIGANDS FOR THERAPEUTIC USE 7TM Pharma A/S (DK) 2007-03-07 EP disclosed
WO-2005115374-A1 CRTH2 RECEPTOR LIGANDS FOR THERAPEUTIC USE 7TM PHARMA A/S (DK) 2005-12-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105218-A1 CRTH2 Receptor Ligands For Therapeutic Use NR1H2, NR1H3, HRH2 KMT2A 2570/4885MEN1 2859/4885PKM 4396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.